Significant 34% and 33% reduction in AD-TAU-induced seeded Tau aggregation were obtained with 2 μM FT671 and 2 μM Spautin-1, respectively (Figure 4B), similar to the reductions in CTX from rTg4510 (Figure 5A). The gene discussed is MAPT; the disease is Alzheimer disease.